Skip to main content
E

EverEx

EverEx offers a Class II‑cleared digital therapeutic platform that uses AI‑driven musculoskeletal analysis (MORA Vu) to generate prescription‑grade, adaptive exercise programs for patients with joint disorders. The system provides remote assessments, real‑time clinician dashboards, and HIPAA‑compliant cloud storage, and integrates with EHR and telehealth workflows. It serves orthopedic surgeons, physiatrists, physical therapists, and outpatient clinics seeking evidence‑based home rehabilitation.

Seoul, South KoreaFounded 201940700+ followers
Updated 3 months ago

Funding

$6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Patients with musculoskeletal disorders often face limited access to personalized rehabilitation due to geographic constraints, high clinic visit costs, and a lack of data-driven treatment plans. Traditional therapy relies on in‑person sessions and generic exercise regimens, which can delay recovery and reduce adherence.

Solution

EverEx delivers a digital therapeutic platform that combines AI‑powered musculoskeletal analysis with prescription‑grade exercise programs, enabling clinicians to assess and treat patients remotely. The MORA Vu software, certified as a Class II medical device, captures joint alignment and movement metrics using standard imaging and sensor data. Based on a model trained on over 700,000 clinical data points, the system generates individualized rehabilitation protocols that adapt to patient progress. MORA Cure, an FDA‑IDE‑approved digital therapeutic for patellofemoral pain syndrome, guides patients through home‑based exercises while transmitting adherence and performance data to a secure cloud. Clinicians access real‑time dashboards and outcome analytics, allowing evidence‑based adjustments without additional office visits. The platform is designed for deployment on consumer devices, making evidence‑based rehab available anytime, anywhere.

Target Audience

The primary customers are orthopedic surgeons, physiatrists, and physical therapists seeking remote assessment and prescription tools, as well as hospitals and outpatient clinics that provide musculoskeletal rehabilitation services. It also serves patients with acute or chronic joint disorders who require convenient, evidence‑based home therapy.

Features

  • AI-driven musculoskeletal analysis engine (MORA Vu) with Class II medical device certification for precise joint assessment
  • Digital therapeutic module (MORA Cure) for patellofemoral pain syndrome, cleared for pivotal clinical trials under IDE approval
  • Adaptive exercise prescription algorithm trained on 700,000+ patient data points, delivering personalized rehab plans that evolve with patient performance
  • Cloud‑based data pipeline with secure, HIPAA‑compliant storage and end‑to‑end encryption for patient metrics and session logs
  • Clinician web portal featuring real‑time progress dashboards, compliance tracking, and automated outcome reporting
  • Cross‑platform mobile app enabling patients to perform guided exercises at home, with sensor integration for motion capture and feedback
  • API hooks for integration with electronic health record (EHR) systems and telehealth platforms, supporting seamless workflow adoption
This profile is AI-generated and may contain inaccuracies.